Article information
Full text is only aviable in PDF
Bibliografía
[1.]
K. Toman.
Quel est le mecanisme biologique de la chimiothérapie?.
Depistage et chimiotherapie de la tuberculose. Paris, New York, Barcelonne, Milan: Ed. Masson, (1980), pp. 81-84
[2.]
E.J. Pérez-Stable.
Hopewell Phc. Current tuberculosis treatment regimens.
Clin Chest Med, 10 (1989), pp. 323-339
[3.]
J. Grosset.
Bacteriologics basis of short-course chemotherapy for tuberculosis.
Clin Chest Med, 1 (1980), pp. 231-241
[4.]
K. Toman.
Qu’entend-on par chimiothérapie intermittenet et sur quelles bases scientifiques repse-t-elle? Depistage et chimiothéra pie de la tuberculose.
Ed. Masson, (1980), pp. 141-145
[5.]
D.J. Girling.
The chemotherapy of tuberculosis.
The biology of the mycobacteria. Vol 3. Clinical aspects of mycobacterial dissease, Academic Press, (1989), pp. 285-323
[6.]
W. Fox, D.A. Mitchinson.
Short-course chemotherapy for pulmonary tuberculosis.
Am Rev Respir Dis, 111 (1975), pp. 325-353
[7.]
D.A. Mitchinson.
The action of antituberculosis drugs in shortcourse chemotherapy.
Tubercle, 66 (1985), pp. 219-225
[8.]
J. Grosset.
Present status of chemotherapy for tuberculosis.
Rev Infect Dis, 2 (1989), pp. s347-s352
[9.]
A. Jindani, V.R. Aber, E.A. Edwards, D.A. Mitchinson.
The early bactericial activity of drugs in patients with pulmonary tuberculosis.
Am Rev Respir Dis, 121 (1980), pp. 939-948
[10.]
J.M. Dickinson, D.A. Mitchinson.
Experimental models to explain the high sterilizing activity of rifampin in the chemotherapy of tuberculosis.
Am Rev Respir Dis, 123 (1981), pp. 367-371
[11.]
M.A. Steele, R.M. Desprez.
The role of pyrazinamide in tubercu losis chemotherapy.
Chest, 94 (1988), pp. 845-850
[12.]
N.A. D’Esopo.
Clinicla trials in pulmonary tuberculosis.
Am Rev Respir Dis, 125 (1982), pp. 85-93
[13.]
East African/British Medical Research Councils.
Controlled clinical trial of short-course (6 month) regimens of chemotherapy for treatment of pulmonary tuberculosis.
Lancet, 1 (1972), pp. 1.079-1.085
[14.]
East African/British Medical Research Councils.
Controlled clinical trial of four short-course (6 month) regimens of chemothe rapy for treatment of pulmonary tuberculosis.
Second report. Lancet, 1 (1973), pp. 1.331-1.338
[15.]
East African/British Medical Research Councils.
Controlled clinical trial of four short-course (6 month) regimens of chemothe rapy for treatment of pulmonary tuberculosis.
Third report. Lancet, 2 (1974), pp. 237-240
[16.]
K. Toman.
Quelle est 1’efficacité de la chimiothérapie de courte-durée et que’1 est son avenir? Depistage et chimiothérapie de la tuberculose.
Ed. Masson, (1980), pp. 194-212
[17.]
Second East African/British Medical Research Council Study.
Controlled clinical trial of four short-course (6 month) regimens of chemotherapy for treatment of pulmonary tuberculosis.
Lancet, 2 (1974), pp. 1.100-1.106
[18.]
K. Toman.
Quel est le but de la phase intensive initiale dans la chimiothérapie en deux phases? Dépistage et chimiothérapie de la tuberculose.
Ed. Masson, (1980), pp. 154-156
[19.]
Second East African/British Medical Research Council Study.
Controlled clinical trial of four short-course (6 month) regimens of chemotherapy for treatment of pulmonary tuberculosis.
Second re port. Am Rev Respir Dis, 114 (1976), pp. 471-475
[20.]
Third East African/British Medical Research Council Study.
Controlled clinical trial of four short-course regimens of chemothe rapy for two durations in the treatment of pulmonary tuberculosis.
Am Rev Respir Dis, 118 (1978), pp. 39-48
[21.]
Third East African/British Medical Research Council Study.
Controlled clinical trial of four short-course regimens of chemothe rapy for two durations in the treatment of pulmonary tuberculosis.
Second report. Tubercle, 61 (1980), pp. 59-69
[22.]
Singapore Tuberculosis Service/British Medical Research Councils.
Clinical trial of six-mont and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis.
Am Rev Respir Dis, 119 (1979), pp. 579-585
[23.]
Singapore Tuberculosis Service/British Medical Research Councils.
Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis.
The results up to 30 months. Tubercle, 62 (1981),
[24.]
East, Central African/British Medical Research Councils.
Fifth collaborative study.
Controlled trial of 4 short-course regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis. First report. Tubercle, 6 (1983), pp. 153-166
[25.]
Singapore Tuberculosis Service/British Medical Research Council.
Clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis.
Am Rev Respir Dis, 132 (1985), pp. 374-378
[26.]
American Thoracic Society.
Guidelines for short-course tu berculosis chemotherapy.
Am Rev Respir Dis, 121 (1980), pp. 611-614
[27.]
Singapore Tuberculosis Service/Bristish Medical Research Council.
Long term follow-up of a clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmo nary tuberculosis.
Am Rev Respir Dis, 133 (1986), pp. 779-783
[28.]
Singapor Tuberculosis Service/British Research Council.
Five year follow-up ot a clinical trial of three 6-month regimens of chemo therapy given intermittently in continuation phase in the treatment of pulmonary tuberculosis.
Am Rev Respir Dis, 137 (1988), pp. 1.147-1.150
[29.]
Hong Kong Tuberculosis Treatment Service/British Medical Research Councils.
Controlled trial of 6-month and 9-month regi mens of daily and intermittent streptomycin plus isoniazid plus pyrazinamide for pulmonary tuberculosis in Hong Kong.
Tubercle, 56 (1975), pp. 81-96
[30.]
Hong Kong Chest Service/British Medical Research Council.
Controlled trid of 6-month and 9-month regimens of daily and intermittent streptomycin plus isoniazid plus pyrzinamide for pul monary tuberculosis in Hong Kong.
The results up to 30 months. Am Rev Respir Dis, 115 (1977), pp. 727-735
[31.]
Hong Kong Chest Service/British Medical Research Council.
Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis.
First report. Am Rev Respir Dis, 118 (1978), pp. 219-227
[32.]
Hong Kong Chest Service/British Medical Research Council.
Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis.
The results up to 24 months. Tubercle, 60 (1979), pp. 201-202
[33.]
Hong Kong Chest Service/British Medical Research Council.
Controlled trial of four thrice-weekly regimens and daily regimen all given for 6 months for pulmonary tuberculosis.
Lacet, 1 (1981), pp. 171-174
[34.]
Hong Kong Chest Service/British Medical Research Council.
Controlled trial of 4 three times weekly regimens and daily regimen all given for 6 months for pulmonary tuberculosis.
Second report. The results up to 24 monts. Tubercle, 63 (1982), pp. 89-98
[35.]
Hong Kong Chest Service/British Medical Research Council.
Five year follow-up of a Controlled trial of five 6-month regimens of chemotherapy for pulmonary tuberculosis.
Am Rev Respir Dis, 136 (1987), pp. 1.339-1.342
[36.]
J. Grosset, C.H. Truffot-Pernot, S. Poggi, H. Lecoeur, C.L. Chastang.
Prevention de la resistence a la rifampicine par la pyrazinamide dans la tuberculose experimentale de la souris.
Rev Mal Resp, (1984), pp. 2.205-2.208
[37.]
P. Chaulet, F. Boulahabal, N. Khaled Ait, Z. El Awadi, M. Tazir.
Comparisson de trois regimens de chimiothérapie de 6 mois dans la tuberculose pulmonaire on practique de routine a Alger.
Rev Fr Mal Resp, 11 (1983), pp. 667-676
[38.]
L. Mazouni, M. Tazir, F. Boulahbal, P. Chaulet.
Enquet controlée comparant trois regimens de chimiothérapie quotidienne de six mois dans la tuberculose pulmonaire en practique de routine a Alger.
Results au 30 mois. Rev Mal Respir, 2 (1985), pp. 209-214
[39.]
D.A. Mitchinson, A.J. Nunn.
Influence of initial drug resistence on the response to short-course chemotherapy of pulmonary tu berculosis.
Am Rev Respir Dis, 133 (1986), pp. 423-430
[40.]
K. Toman.
Dans quelle mesure la resistence initial aux medicaments et les tests de sensibilité avant traítment ont-ils de 1’interet pour le choix des regimens therápeutiques? Depistage et chimiothé rapie de la tuberculose.
Ed. Masson, (1980), pp. 177-183
[41.]
J.H. Angel.
British Thoracic Association. Short-course chemo therapy.
Chest, 80 (1981), pp. 722-724
[42.]
British Thoracic Association.
Short-course chemotherapy in pulmonary tuberculosis.
Lancet, 1 (1980), pp. 1.182-1.183
[43.]
G. Roussel.
Resultats lointains d’un essai de chimiothérapie de courte-durée. L’enquet francaise 6.9.12.
Rev Fr Mal Respir, 11 (1983), pp. 847-857
[44.]
R. Rey Duran, F.J. Guerra Sanz.
Clinical trial of short-course chemotherapy regimens (6-month) in patients weith newly detected pulmonary tuberculosis.
Bull IUAT, 54 (1979), pp. 30-31
[45.]
J. Carreras, A. Ramos, R. Rey.
Tratamientos cortos en tubercu losis inicial (6 meses).Resultados a los 10 años de seguimiento.
Arch Bronconeumol, 25 (1989), pp. 35
[46.]
P. Miret, E. Balada.
Six month treatment of pulmonary tu berculosis by a combination of isoniazid, rifampicin and pyrazina mide.
Bull IUAT, 54 (1979), pp. 11-12
[47.]
P. Miret, E. Balada.
Tratamiento de la tuberculosis pulmonar con una asociación de isoniazida y rifampicina más pirazinamida, durante seis meses.
Rev Enf Tórax, 109 (1979), pp. 28-32
[48.]
British Thoracic Association.
A Controlled trial of six months chemotherapy in pulmonary tuberculosis.
Second report. Results. during the 24 months after the end of chemotherapy. Am Rev Respir Dis, 126 (1982), pp. 460-462
[49.]
Algerian Work Group/British Medical Research Council.
Cooperative study. Controlled clinical trial comparing a 6-month and 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara.
Am Rev Respir Dis, 129 (1984), pp. 921-928
[50.]
D. Snider, M. Long, M. Zierski, J. Rogowski, E. Bek.
Preliminary results of six month regimens studied in the United States and in Polland.
Chest, 80 (1981), pp. 727-729
[51.]
D. Snider, M. Lolng, F. Cross, L.S. Farer.
Six months isoniazidrifampicin therapy for pulmonary tuberculosis. Report of a USPHS cooperative trial.
Am Rev Respir Dis, 129 (1984), pp. 573-579
[52.]
U. Geiter, R.J. O’Brien, S. Snider.
Short course chemotherapy of pulmonary tuberculosis. Preliminary results of USPHS therapy, trial 21.
Am Rev Respir Dis, 133 (1986), pp. A205
[53.]
D.L. Combi, R.J. O’Brien, D. Snider.
USPHS tuberculosis the rapy, trial 21. Results at two years of follow-up.
Am Rev Respir Dis, 134 (1989), pp. A315
[54.]
L. Debra, M.P.H. Combs, R.J. O’Brien, L.J. Geiter.
USPHS, trial 21: Effectiveness, toxicity and acceptability. The repon of final result.
Ann Intern Med, 112 (1990), pp. 397-406
[55.]
M. Zierski, E. Bek, M. Long, D. Snider.
Short-course (6 month). Cooperative tuberculosis study in Polland. Results 30 months after completion of treatment.
Am Rev Respir Dis, 124 (1981), pp. 249-251
[56.]
D. Snider, J. Rogowski, M. Zierski, E. Bek, M. Long.
Succesful intermittent treatment of smear-positive pulmonary tuberculosis in six months: A cooperative study in Polland.
Am Rev Respir Dis, 126 (1982), pp. 265-267
[57.]
D. Snider, J. Grazcyc, E. Bek, J. Rogowski.
Supervised six months treatment of newly diagnosed pulmonary tuberculosis using isoniazid, rifampicin and pyrazinamide, with and without streptomycin.
Am Rev Respir Dis, 130 (1984), pp. 1.091-1.094
[58.]
A. Castelo, S. Golhman, M.A. Dalbon, J.R.B. Jardim, A.S. Kalckman, E.A. Da Silva.
Comparison of daily and twice-weekly regimens to treat pulonary tuberculosis.
Lancet, 2 (1989), pp. 1.173-1.176
[59.]
H. Prabhakar.
Tuberculosis Research Centre.
Madras. Regí menes completamente intemitentes contra la tuberculosis pulmonar en el sur de la India. Bol VICTER, 62 (1987), pp. 24-26
[60.]
H. Eule, H. Beck.
Evers. Daily and intermittent short-course chemotherapy using for drugs in recently detected baccilary pulmo nary tuberculosis.
Bull IUAT, 52 (1982), pp. 63
[61.]
Recomendaciones de la Comisión de Tratamiento (UICTER).
Regímenes de quimioterapia antituberculosa.
Bol UICTER, 63 (1988), pp. 64-69
[62.]
J.L. Martínez de Salinas, C. Lacasa, J. Etura, J. Laparra, I. Aguirre.
Tratamiento breve de la tuberculosis pulmonar. Estudio de cien casos.
Arch Bronconeumol, 23 (1987), pp. 37
[63.]
R. Vidal, J. De Gracia, E. Fité, J. Ruiz, M. Vizcaya, A. Riba.
Comparación entre 2 pautas de 6 y 9 meses en el tratamiento inicial de 569 Tbc respiratorias.
Arch Bronconeumol, (1986), pp. 52
[64.]
J. Sauret, J.L. Heredia, R. Cornudella.
Resultados de dos pautas de 6 meses en el tratamiento de la tuberculosis pulmonar.
Med Clin (Barc), 89 (1987), pp. 177-179
[65.]
F. González, J.A. Pérez, F. Dolz, C. Pellicer, R. Navarro, A. Perales.
Estudio de 1.100 casos de tratamientos cortos de seis meses en tuberculosis pulmonar.
Arch Bronconeumol, 25 (1989), pp. 35
[66.]
T. Romanillos, A. Casagrán, E. Barbeta, et al.
Tuberculosis pulmonar: eficacia y tolerancia de la pauta de tratamiento de seis meses con cuatro fármacos.
Rev Clin Esp, 186 (1990), pp. 116-118
[67.]
V. Farga, P. Valenzuela, A. Yáñez, et al.
Short-course chemothe rapy of tuberculosis. A 7-month regimen with an initial intensive phase of one month.
Am Rev Respir Dis, (1984), pp. A185
[68.]
B. Kreis, S. Pretet.
Deux traitements de trois mois pour des tuberculeux pulmonaires. Procedings of the XXIIIrd International Tuberculosis Conference, México, 1975.
Bull IUAT, 51 (1976), pp. 75-79
[69.]
Tuberculosis Research Centre, Madras, National Tubercu losis Institute, Bangalore.
A controlled clinical trial of 3-and-5 month regimens in the treatment of sputum-positive pulmonary tuberculosis in South-India.
Am Rev Respir Dis, 134 (1986), pp. 27-33
[70.]
M.L. Mehrotra, K.D. Gautam, C.K. Chaube.
Shortest possible acceptable effective ambulatory chemotherapy in pulmonary tu berculosis: Preliminary report I.
Am Rev Respir Dis, 124 (1981), pp. 239-244
[71.]
M.L. Mehrotra, K.D. Gautam, C.K. Chaube.
Shortest possible. acceptable, effective chemotherapy in ambulatory patients with pulmonary tuberculosis.
Am Rev Respir Dis, 129 (1984), pp. 1.016-1.017
[72.]
East African, British Medical Research Councils.
Contro lled clinical trial of five short-course (4-month) chemotherapy regi mens in pulmonary tuberculosis. First repon of 4th study.
Lancet, 2 (1978), pp. 334-338
[73.]
East African, British Medical Research Councils.
Contro lled clinical trial of five short-course (4-month) chemotherapy regi mens in pulmonary tuberculosis. First report of 4th study.
Am Rev Respir Dis, 123 (1981), pp. 165-170
[74.]
S. Pretet, J. Grosset, S. Perdrizet.
Evaluación de un tratamiento de 18 semanas que incluye la pirazinamida (resultados prelimina res).
Bol de la UICT, 53 (1978), pp. 252-253
[75.]
S. Pretet.
Chimiothérapie de courte-durée de la tuberculose. Essai cooperatif francaise.
Rev Fr Mal Resp, 11 (1983), pp. 859-866
[76.]
L.J. González Montaner, O.R. Palma Beltrán, E.H. Abbate, et al.
Ultra-short course treatment of tuberculosis.
Am Rev Respir Dis, 129 (1984), pp. A201
[77.]
L.J. González Montaner, O.R. Palma Beltrán, A. Dambrosi, M. Leo nardo, C. Mosca, C. Bence.
Four drugs, 18-week pulmonary tu berculosis treatment. Results after two years follow-up.
Am Rev Respir Dis, 135 (1987), pp. A137
[78.]
S.P. Tripathy.
Quimioterapia de corta duración de la tubercu losis.
Investigación de Madras. Bol de la UICT, 54 (1979), pp. 30-32
[79.]
Tuberculosis Research Centre, Madras.
Study of chemothe rapy regimens of 5 and 7 months’ duration and the role of corticosteroids in the treatment of sputum-positive patients with pulmonary tuberculosis in South India.
Tubercle, 64 (1983), pp. 73-91
[80.]
T. Santha, O. Nazareth, M.S. Krishnamuny, et al.
Tuberculosis Research Centre.
Madras. Treatment of pulmonary tuberculosis with short-course chemotherapy in South-India. 5 year follow-up. Tubercle, 70 (1989), pp. 229-234
[81.]
V. Farga, P. Valenzuela, M.T. Valenzuela, et al.
Quimioterapia abreviada de tuberculosis con esquemas de 5 meses de duración con y sin pirazinamida en la segunda fase (Ta-82).
Rev Med Chile, 114 (1986), pp. 701-706
[82.]
K. Toman.
Combien y a-t-il de bacilles dans un échantillon de crachats dont le est positif á 1’examen direct? Dépistage et chimiothérape de la tuberculose.
Ed. Masson, (1980), pp. 6-8
[83.]
K. Toman.
Dans quelle mesure peut-on se fier á la microscopie directe? Dépistage et Chimiothérapie de la tuberculose.
Ed. Masson, (1980), pp. 14-22
[85.]
K. Toman.
Quel rendement supplementaire obtient-on lorsqu’on répète les examens des crachats para microscopie directe et par culture? Dépistage et Chimiothérapie de la tuberculose.
Ed. Masson, (1980), pp. 40-50
[86.]
H.M. Sommers.
The laboratory diagnosis of mycobacterial disease.
Tuberculosis, pp. 404-424
[87.]
Hong Kong Chest Service.
Tuberculosis Research Centre. Ma dras and British Medical Research Council. Sputum-smear-negative pulmonary tuberculosis. Controlled trial of 3-month and 2-month regimens of chemotherapy, 1 (1979), pp. 1.361-1.363
[88.]
Hong Kong Chest Service.
Tuberculosis Research Centre. Madras. British Medical Research Council. A controlled trial of 3-month, 4 month and 6-month regimens of chemotherapy for spu tum-smear-negative pulmonary tuberculosis. Results at 5 years, 139 (1989), pp. 871-876
[89.]
K. Toman.
Quelle est la signification clinique et épidémiologique d’une negativité persistante des frottis chez les sujets dont les cultures seules sont positives? Dépistage et Chimiothérapie de la tuberculose.
Ed. Masson, (1980), pp. 51-57
[90.]
Hong Kong Chest Service.
Tuberculosis Research Centre. Madras. British Medical Research Council. A controlled trial of 2-month, 3-month and 12 month regimens of chemotherapy for smear-negative pulmonary tuberculosis: The results at 30 months.
Am Rev Respir Dis, 124 (1981), pp. 138-142
[91.]
Hong Kong Chest Service.
Tuberculosis Research Centre. Madras. British Medical Research Council. A controlled trial of 2-month, 3-month and 12 month regimens of chemotherapy of sputum-smear-negative pulmonary tuberculosis. Results at 60 months.
Am Rev Respir Dis, 130 (1984), pp. 23-28
[92.]
W. Fox.
The chemotherapy of pulmonary tuberculosis. A review.
Chest, S 76 (1979), pp. 785-796
[93.]
K. Toman.
Qu’entend-on par chimiothérapie en deux phases et traitment “efficace á 100 p. cent”? Dépistage et chimiothérapie de la tuberculose.
Ed. Masson, (1980),
[94.]
W. Fox.
A dónde va la quimioterapia de corta duración.
Bol de la UICT, 56 (1981), pp. 147-170
[95.]
A.K. Dutt, D. Moers, W.W. Stead.
Short-course chemotherapy for tuberculosis with mainly twice-weekly isoniazid and rifampin: Community physicians seven-year experience with mainly outpatients.
Am J Med, 77 (1984), pp. 233-242
[96.]
A.K. Dutt, D. Moers, C. Thomas, W.W. Stead.
Short-course chemotherapy for six months in smear-negative pulmonary and pleural tuberculosis.
Am Rev Respir Dis, 127 (1983), pp. 192
[97.]
A.K. Dutt, D. Moers, W.W. Stead.
Smear-negative, culture-positive pulmonary tuberculosis. Six-month chemotherapy with isoniazid and rifampin.
Am Rev Respir Dis, 141 (1990), pp. 1.232-1.236
[98.]
A.K. Dutt, D. Moers, W.W. Stead, C. Alvin.
Smear and culture negative tuberculosis: can the duration of therapy be shortened?.
Am Rev Respir Dis, 135 (1987), pp. A137
[99.]
A. Granados, F. Manresa, I. Galarza, R. Estopá.
Pleuritis tu berculosa. Tratamiento con INH-RIF durante 6 meses. Primeros resultados.
Arch Bronconeumol, 24 (1988), pp. 12
[100.]
A.K. Dutt, D. Moers, W.W. Stead.
Smear-and-culture-negative pulmonary tuberculosis. Four month short-course chemotherapy.
Am Rev Respir Dis, 139 (1989), pp. 867-870
[101.]
C.J.L. Murray, K. Styblo, A. Rouillon.
Tuberculosis en los países en desarrollo, magnitud, intervenciones y costos.
Bol UICTER, 65 (1990), pp. 6-26
[102.]
J. Sbarbaro.
To treat or not to treat, that was the question.
Am Rev Respir Dis, 139 (1989), pp. 865-866
Copyright © 1991. Sociedad Española de Neumología y Cirugía Torácica
